Niche BioMg Target medical device manufacturers and surgical implant providers with BioMg, a bio-absorbable magnesium alloy offering temporary structural support, addressing the need for temporary reinforcement without permanent implants.

Early Stage With revenue under $1M and 0-1 employees, nanoMAG represents a small, agile partner for pilot programs or early adopters in academia or industry seeking innovative biomaterials.

Clinical Advantage Position BioMg as a solution to reduce complications from permanent implants, highlighting potential for shorter patient recovery times and fewer revision surgeries to appeal to hospitals and surgical centers.

Strategic Partnerships Explore collaborations with established medical device manufacturers and contract manufacturers to scale production, quality systems, and regulatory pathways while leveraging existing distribution channels.

Growth Signals Leverage proximity to Livonia, MI, and the broader US biomaterials ecosystem to target regional grants, academic partnerships, and supplier networks looking for innovative magnesium-based biomaterials.